Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Document Type
Article
Publication Date
9-2014
Digital Object Identifier (DOI)
http://dx.doi.org/10.1148/radiol.14110885
Related Content
Case 213: Primary Splenic Angiosarcoma, published in Radiology, v. 274, no. 1, p. 298-303, DOI: http://dx.doi.org/10.1148/radiol.14110919
Also available in UKnowledge: http://uknowledge.uky.edu/radiology_facpub/4/
Repository Citation
Krol, John J.; Krol, Vera V.; Dawkins, Adrian; and Ganesh, Halemane S., "Case 213" (2014). Radiology Faculty Publications. 3.
https://uknowledge.uky.edu/radiology_facpub/3
Fig. 1.ppt-2015.12.21_13.15.00.566.ppt (118 kB)
Figure 1: Axial T1-weighted (repetition time msec/echo time msec, 400/17; 5-mm section thickness) contrast-enhanced MR image of the brain (10 mL of gadopentetate dimeglumine administered intravenously over 15 seconds, Magnevist; Bayer Healthcare Pharmaceuticals, Leverkusen, Germany).
Figure 2.ppt-2015.12.21_13.16.02.872.ppt (75 kB)
Figure 2: Transverse gray-scale US image of the upper abdomen.
Figure 3.ppt-2015.12.21_13.16.10.797.ppt (88 kB)
Figure 3: Axial contrast-enhanced CT image of the chest acquired during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec, Omnipaque 300; GE Healthcare, Milwaukee, Wis).
Figure 4a.ppt-2015.12.21_13.16.23.979.ppt (115 kB)
Figure 4a: (a, b) Axial contrast-enhanced CT images of the liver during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec).
Figure 4b.ppt-2015.12.21_13.16.31.919.ppt (126 kB)
Figure 4b: (a, b) Axial contrast-enhanced CT images of the liver during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec).
Figure 5.ppt-2015.12.21_13.16.40.328.ppt (98 kB)
Figure 5: Coronal T2-weighted (900/78, 6-mm section thickness) ultrafast spin-echo MR image of the abdomen (Symphony; Siemens Medical Systems, Erlangen, Germany).
Figure 6a.ppt-2015.12.21_13.16.51.373.ppt (93 kB)
Figure 6a: Axial T1-weighted (4.3/2; 2-mm section thickness) dynamic contrast-enhanced ultrafast gradient-echo MR images of the abdomen (10 mL of gadopentetate dimeglumine) obtained during the (a) early and (b) late arterial phases.
Figure 6b.ppt-2015.12.21_13.17.18.95.ppt (90 kB)
Figure 6b: Axial T1-weighted (4.3/2; 2-mm section thickness) dynamic contrast-enhanced ultrafast gradient-echo MR images of the abdomen (10 mL of gadopentetate dimeglumine) obtained during the (a) early and (b) late arterial phases.
Figure 7.ppt-2015.12.21_13.17.54.147.ppt (124 kB)
Figure 7: Unenhanced axial CT image of the head at the time of acute mental status changes and clinical deterioration.
Figure 1: Axial T1-weighted (repetition time msec/echo time msec, 400/17; 5-mm section thickness) contrast-enhanced MR image of the brain (10 mL of gadopentetate dimeglumine administered intravenously over 15 seconds, Magnevist; Bayer Healthcare Pharmaceuticals, Leverkusen, Germany).
Figure 2.ppt-2015.12.21_13.16.02.872.ppt (75 kB)
Figure 2: Transverse gray-scale US image of the upper abdomen.
Figure 3.ppt-2015.12.21_13.16.10.797.ppt (88 kB)
Figure 3: Axial contrast-enhanced CT image of the chest acquired during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec, Omnipaque 300; GE Healthcare, Milwaukee, Wis).
Figure 4a.ppt-2015.12.21_13.16.23.979.ppt (115 kB)
Figure 4a: (a, b) Axial contrast-enhanced CT images of the liver during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec).
Figure 4b.ppt-2015.12.21_13.16.31.919.ppt (126 kB)
Figure 4b: (a, b) Axial contrast-enhanced CT images of the liver during the arterial phase (80 mL of iohexol 300 administered at a rate of 4 mL/sec).
Figure 5.ppt-2015.12.21_13.16.40.328.ppt (98 kB)
Figure 5: Coronal T2-weighted (900/78, 6-mm section thickness) ultrafast spin-echo MR image of the abdomen (Symphony; Siemens Medical Systems, Erlangen, Germany).
Figure 6a.ppt-2015.12.21_13.16.51.373.ppt (93 kB)
Figure 6a: Axial T1-weighted (4.3/2; 2-mm section thickness) dynamic contrast-enhanced ultrafast gradient-echo MR images of the abdomen (10 mL of gadopentetate dimeglumine) obtained during the (a) early and (b) late arterial phases.
Figure 6b.ppt-2015.12.21_13.17.18.95.ppt (90 kB)
Figure 6b: Axial T1-weighted (4.3/2; 2-mm section thickness) dynamic contrast-enhanced ultrafast gradient-echo MR images of the abdomen (10 mL of gadopentetate dimeglumine) obtained during the (a) early and (b) late arterial phases.
Figure 7.ppt-2015.12.21_13.17.54.147.ppt (124 kB)
Figure 7: Unenhanced axial CT image of the head at the time of acute mental status changes and clinical deterioration.
Notes/Citation Information
Published in Radiology, v. 272, no. 3, p. 911-913.
© RSNA, 2014
The copyright holders have granted the permission for posting the article here.